Book a Meeting

Non-Fucosylated Anti-Human TNF receptor 1 (GSK 1995057) Therapeutic Antibody (CAT#: BioBet-1382ZP) Datasheet

Target
TNF receptor 1
Isotype
IgG
Description
ADCC-Enhanced anti-TNF receptor 1 (GSK 1995057) is a non-fucosylated therapeutic biobetter antibody engineered by Creative Biolabs' Afuco™ technology platform.
Indication
Acute Lung Injury
Classification
Therapeutic antibody; biobetter

Cooperation Seeking

Creative Biolabs is interested in collaborating with potential partners (include but not limit to major pharma or biotech firms) to further co-develop ADCC-enhanced TNF receptor 1 antibody. For commercial partners interested in our ADCC-enhanced therapeutic antibodies, Creative Biolabs welcomes collaboration. Here are two ways for your choice, and please contact us for more details.
1) Collaborate with us and co-develop the programs from discovery phase to IND enabling. Costs will be shared.
2) Become a licensed candidate of our programs.
Looking forward to cooperating with you in the near future.
Official Name
TNFRSF1A
Full Name
tumor necrosis factor receptor superfamily, member 1A
Background
The protein encoded by this gene is a member of the TNF-receptor superfamily. This protein is one of the major receptors for the tumor necrosis factor-alpha. This receptor can activate NF-kappaB, mediate apoptosis, and function as a regulator of inflammation. Antiapoptotic protein BCL2-associated athanogene 4 (BAG4/SODD) and adaptor proteins TRADD and TRAF2 have been shown to interact with this receptor, and thus play regulatory roles in the signal transduction mediated by the receptor. Germline mutations of the extracellular domains of this receptor were found to be associated with the autosomal dominant periodic fever syndrome. The impaired receptor clearance is thought to be a mechanism of the disease.
Alternative Names
TNFRSF1A; tumor necrosis factor receptor superfamily, member 1A; FPF; MS5; p55; p60; TBP1; TNF-R; TNFAR; TNFR1; p55-R; CD120a; TNFR55; TNFR60; TNF-R-I; TNF-R55; TNFR1-d2; tumor necrosis factor receptor superfamily member 1A; TNF-R1; TNF-RI; TNFR-I; tumor necrosis factor-alpha receptor; tumor necrosis factor receptor type 1; tumor necrosis factor binding protein 1; tumor necrosis factor receptor 1A isoform beta
Gene ID
Cellular Localization
Plasma membrane, Extracellular region or secreted, Golgi apparatus
Involvement in Disease
Diseases associated with TNFRSF1A include Periodic Fever, Familial, Autosomal Dominant and Multiple Sclerosis 5.
Related Pathways
Its related pathways are Apoptosis Modulation and Signaling and Signal transduction_JNK pathway.
Function
The receptor TNFSF2/tnf-and the homotrimer TNFSF1/lymphtoxin-. The adaptor molecule FADD recruits caspase-8 to the activated receptor. The resulting death-inducing signal complex (DISC) performs proteolytic activation of caspase-8, which in turn initiates a cascade of caspase (aspartate-specific cysteine protease) and mediates apoptosis. Helps induce non-cell-killing TNF effects, including antiviral status and activation of acid sphingomyelinase
Field of research
Cell Biology and Cellular Response antibody; Cell Death antibody; Immune System antibody; Signaling Transduction antibody
Post-translational modifications
The soluble form is produced from the membrane form by proteolytic processing.
Biologic Classification
Protein Based Therapies
Monoclonal antibody (mAb)
Antibody Isotype
IgG
Antibody Clone
GSK 1995057
Host
Human
Species Reactivity
Human
Description
GSK1995057 is a fully human, single domain antibody directed against the TNFR1 receptor, used for acute lung injury.
Indication
Acute Lung Injury

Acute Lung Injury

All products and services are for Research Use Only. Do Not use in humans.

ONLINE INQUIRY

Creative Biolabs has established a team of customer support scientists ready to discuss ADCC/CDC optimization strategies, antibody production, bioinformatics analysis and other molecular biology/biotechnology issues.

  • *
  • *
  • *
USA

UK

Germany

ISO 9001 Certified - Creative Biolabs Quality Management System.